Browsing by Author Lencioni, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 3 to 7 of 7 < previous 
TitleAuthor(s)Issue DateViews
 
Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cm
Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013
Tak, WYLin, SMWang, YZheng, JIzzo, FPark, SYChen, MHWong, SNXu, RPeng, CYChiou, YYHuang, GTLee, JYSherman, MAbdullah, BJJLee, JSWang, JHBorys, NPoon, RTPLencioni, R
-
53
 
A Phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC)
Proceeding/Conference:Journal of Hepatology
Yau, TYen, CJChen, PJChau, YLencioni, RKallender, HOttesen, LHPoon, RTP
2011
218
 
A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC)
Proceeding/Conference:Journal of Clinical Oncology
Yau, TCCSukeepaisarnjaroen, WChao, YYen, CJLausoontornsiri, WChen, PJSanpajit, TLencioni, RCamp, ACCox, DSKallender, HOttesen, LHPoon, RTP
2012
88
 
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
Journal:Journal for ImmunoTherapy of Cancer
Greten, TFAbou-Alfa, GKCheng, ALDuffy, AGEl-Khoueiry, ABFinn, RSGalle, PRGoyal, LHe, ARKaseb, AOKelley, RKLencioni, RLujambio, AMabry Hrones, DPinato, DJSangro, BTroisi, RIWilson Woods, AYau, TZhu, AXMelero, I
2021
24
 
Treatment before liver transplantation for HCC
Journal:Annals of Surgical Oncology
Belghiti, JCarr, BIGreig, PDLencioni, RPoon, RT
2008
185
Showing results 3 to 7 of 7 < previous